The global immunochromatography kits market is poised for significant growth, reaching an estimated value of US$12.1 billion by 2032. This upward trend reflects a Compound Annual Growth Rate (CAGR) of 4.1% from 2022, highlighting the increasing importance of these rapid and user-friendly diagnostic tools.
Get Recently Updated Report of Market as Sample Copy!
https://www.futuremarketinsights.com/reports/sample/rep-gb-15764
Combating Infectious Diseases Remains a Priority:
Despite advancements in medicine and sanitation, infectious diseases continue to be a major global health concern. This, coupled with growing awareness of the importance of rapid and accessible diagnostic tools, is driving the demand for immunochromatography kits, particularly in developing economies.
Lateral Flow Assays: Empowering Early Detection:
Immunochromatography kits, often employing lateral flow assays (LFAs), play a vital role in managing infectious and cardiovascular diseases. These user-friendly tests enable early detection of various conditions, including:
- HIV
- Pregnancy
- Hepatitis B
The COVID-19 pandemic further highlighted the critical role of LFAs in facilitating self-testing at home, especially for stigmatized conditions like HIV.
Key Takeaways from Global Immunochromatography Kits Market Market:
- North America holds the largest market share with the US being subject to easy accessibility to technologically improvised diagnostic tools and growing demand for diagnostics through increase in incidences of cancer.
- Coming to Europe, Germany dominates the market due to players like Qiagen pushing for more than 20% of the market share.
- The Asia-Pacific is led by China. This could be credited to growing geriatric population due to prevalence of infectious diseases all across.
Explore The Art of Informed Decision-Making Via Our Methodology: https://www.futuremarketinsights.com/request-report-methodology/rep-gb-15764
Competitive Assay:
- Ortho Clinical Diagnostics, in December 2021, inked an agreement of acquisition with Ortho Clinical Diagnostics for massively expanding the offering of diagnostics.
- Abbott, in January 2021, did receive a CE mark for Panbio rapid antigen test, thereby allowing its usage for self-administered sample collection and asymptomatic screening through nose swab.
- Roche Diagnostics, in September 2020, did launch SARS-CoV-2 Rapid Antigen test.
- Sofia 2 Flu + SARS Antigen FIA (Quidel Corporation), BD Veritor SARS CoV-2 Test (BD), and Rapid Covid-19 Antigen test (Danaher Corporation) were launched at the time of pandemic.
- Abbott Laboratories, in August 2020, inked an agreement with the US government for 150 Mn home-based BinaxNOW Covid-19 tests.
“The basic purpose of immunochromatography kits is that of identifying if target analyte (like an antibody or antigen) is present or not in a sample in cost-effective and timely manner”, says an analyst from Future Market Insights.
What does the Report get into?
- The research study is based on product (readers and kits), by application (sexually transmitted diseases, infectious diseases, diabetes, pregnancy testing, drug of abuse testing, and likewise), and by distribution channel (hospital pharmacies, retail pharmacies, hypermarket/supermarket, and e-Commerce).
- With increase in awareness that immunochromatography assay or lateral flow test simplifies the task of determining of target analyte is missing or present is bound to take the immunochromatography kits market to greater strides in the years to come.
Global Immunochromatography Kits Market Key Companies Profiled:
- Abbott Laboratories
- PerkinElmer Inc.
- Danaher Corporation
- Bio-rad Laboratories
- F. Hoffmann-La Roche AG
- bioMérieux SA
- Becton, Dickinson, and Company
- Siemens Healthineers AG
- Thermo Fisher Scientific Inc.
- QIAGEN
Discover Extensive Market Insights: Purchase Now to Access! https://www.futuremarketinsights.com/checkout/15764
Key Market Segments Covered in Global Immunochromatography Kits Market Industry Research:
By Product:
- Readers
- Kits
By Application:
- Sexually Transmitted Diseases
- Infectious Diseases
- Diabetes
- Pregnancy Testing
- Drug Abuse Testing
- Others
By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Supermarket/Hypermarket
- E-Commerce
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
